CLSA Board of Directors
Officers
William J. Newell
Chair
Chief Executive Officer, Sutro Biopharma, Inc.
Melinda Richter
Vice Chair
Global Head, Johnson & Johnson Innovation, JLABS
Alex Kelly
Treasurer
Executive Vice President, Corporate Affairs and Chief Communications Officer, Allergan
Bruce W. Jenett
Secretary
Senior Counsel, DLA Piper LLP (US)
Members
Wade Ackerman
Partner, Covington & Burling LLP
William Annett
Chief Executive Officer OncoCyte
Michael V. Arbige, Ph.D.
Vice President of R&D, DuPont Biosciences
Rick Ascroft
Senior Vice President, Managed Markets, Takeda Pharmaceuticals USA
Ranjeet Banerjee
Worldwide President, Medication Management Solutions, Becton, Dickinson And Company (BD)
David Beier, J.D.
Managing Director, Bay City Capital
Fritz Bittenbender
Senior Vice President, Government Affairs, Genentech
Ho Sung Cho
Vice President, Biotherapeutics, Celgene
Peter J. Claude
Partner, PwC
David H. Crean
Managing Director & Partner, Objective Capital Partners
Mark Ginestro
Principal, Healthcare and Life Sciences, KPMG
Bryan Giraudo
Chief Financial Officer, Gossamer Bio
Paul Hastings
President and Chief Executive Officer, Nkarta Therapeutics
Thomas Hudson
Vice President, Head of Oncology Discovery and Early Development, AbbVie, Inc.
Vera Janushkowsky
Vice President, Government Relations and Public Affairs, Pfizer
Jeff Jonker
President and CEO, Ambys Medicines
Steve A. Kay, Ph.D., D.Sc.
Director of Convergent Bioscience, Provost Professor of Neurology, Biomedical Engineering and Biological Sciences, University of Southern California
Larry Kwak, M.D., Ph.D.
Vice President and Cancer Center Associate Director
Director, Toni Stephenson Lymphoma Center
Dirksen Lehman
Corporate Vice President, Public Affairs, Edwards Lifesciences
John Maddalon
Principal, Life Science Practice, Deloitte
Sean McCarthy
President and Chief Executive Officer, CytomX
Shlomo Melmed, MB, ChB, MACP
Executive Vice President for Academic Affairs and Dean of the Medical Faculty at Cedars-Sinai Health System
John Melo
Director, President and Chief Executive Officer, Amyris
Alan Mendelson
Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP
Jamey Millar
Senior Vice President, Managed Markets and Government Affairs, GlaxoSmithKline
Keith Murphy
Founder, CEO, and Chairman, Viscient Biosciences
John Nicols
President and Chief Executive Officer, Codexis
Christian W. Nolet
Partner and Life Sciences Industry Leader, West Region, Ernst & Young
Joshua J. Ofman M.D., M.S.H.S
Senior Vice President, Global Value, Access & Policy, Amgen
Michael G. Raab
President and Chief Executive Officer, Ardelyx
Ganesh Raman, Ph.D.
Associate Vice Chancellor for Research, California State University
Stephen Richardson
Co-Chief Executive Officer, Alexandria Real Estate (ARE)
Beth Roberts
Partner, Hogan Lovells US LLP
Wendye Robbins
President & CEO, Blade Therapeutics
Daria Mochly-Rosen, Ph.D.
The George D. Smith Professor in Translational Medicine
Professor, Chemical and Systems Biology, Stanford University School of Medicine
Terry Rosen, Ph.D.
Chief Executive Officer, Arcus Biosciences
George Savage M.D.
Co-Founder, Chief Medical Officer, Proteus Digital Health
Tony Semedo
President, Medtronic Japan
Alex Szidon
Head of West Coast Business Development & Licensing, Merck
Harold E. Van Wart, Ph.D.
Jens Vogel, Ph.D.
President and CEO | Boehringer Ingelheim
Jared Watkin
Senior Vice President, Diabetes Care, Abbott
Rick E Winningham
Chairman and CEO, Theravance Biopharma